Immune Cell Therapy Solution
Immune cell therapy holds immense promise as a treatment approach for various diseases with an immune component including cancer, autoimmune disease, and chronic inflammation. In this therapeutic therapy, specific cell populations are isolated, genetically modified, activated, and expanded to reach the necessary quantities for patient treatment. T cells, NK cells, regulatory T cells (Treg cells), or dendritic cells can be redirected to attack tumors or amplify a local immune response.
AcceGen offers a comprehensive Gene & Cell Therapy service that encompasses a wide range of solutions. From antibody development to gene delivery, immune cell engineering, and phenotype testing, we provide tailored solutions at every stage of the drug development journey.
Our Antibody Development services offer cutting-edge technology and streamlined processes for efficient, high-quality antibody development. With a focus on diverse applications, we enable the production of antibody fragments for various therapeutic and research purposes.
View our Antibody Development Portfolio
AcceGen’s Custom CAR-T service utilizes advanced CAR molecule design to enhance tumor recognition and optimize T cell activation for targeted immunotherapy, resulting in effective CAR-T cells with improved persistence and tumor microenvironment overcoming capabilities.
View our CAR Molecule Design Portfolio
AcceGen’s Immune Cell Preparation services offer high-activity and pure CAR-T, CAR-NK, and general purpose CAR T cells for effective cell research and therapy. We provide solutions to avoid graft-versus-host disease, and streamline large-scale CAR molecule screening using tool cells.
View our Immune Cell Engineering Portfolio
AcceGen offers a diverse range of animal models to support cellular therapy research and gene therapy advancements. Our models, including immunodeficient rodents and large animals, provide valuable insights into disease mechanisms, drug development, and gene modification studies.
View our Animal Models Portfolio
AcceGen, with extensive experience in tumor immunology research, offers a comprehensive array of services to facilitate the development of CAR-T/-NK and other cell therapies. Our services include antibody development, CAR molecular design, CAR lentivirus preparation, immune cell preparation and phenotype testing, cell and animal model construction, as well as in vitro and in vivo efficacy evaluation. AcceGen serves as a reliable partner throughout the entire cell therapy development journey, providing solutions and expert guidance to drive therapies forward on the parth to commercialization.
- Diagnosis and Classification: It identifies specific cell types and stages of maturation, distinguishing normal and abnormal cells associated with leukemia and lymphoma.
- Treatment Guidance: It helps guide treatment decisions, predict disease aggressiveness, and assess treatment effectiveness, aiding in selecting appropriate therapies.
- Targeted Therapies: It enables the use of targeted therapies that selectively attack cancer cells based on their antigen expression, improving treatment outcomes and minimizing side effects.
The image of each service designed by Freepik